Published in Curr Opin Nephrol Hypertens on January 01, 2013
Experimental coronary artery stenosis accelerates kidney damage in renovascular hypertensive swine. Kidney Int (2014) 1.48
Renal autoregulation in health and disease. Physiol Rev (2015) 1.18
Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice. J Diabetes Res (2014) 0.88
Impact of cardiovascular organ damage on cortical renal perfusion in patients with chronic renal failure. Biomed Res Int (2013) 0.85
Role of 24-h ambulatory blood pressure monitoring in children with chronic kidney disease. Indian J Nephrol (2015) 0.85
Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Clin Exp Pharmacol Physiol (2014) 0.84
Klotho Ameliorates Kidney Injury and Fibrosis and Normalizes Blood Pressure by Targeting the Renin-Angiotensin System. Am J Pathol (2015) 0.81
Blood pressure-renal blood flow relationships in conscious angiotensin II- and phenylephrine-infused rats. Am J Physiol Renal Physiol (2013) 0.81
Intraoperative hypotension - a neglected causative factor in hospital-acquired acute kidney injury; a Mayo Clinic Health System experience revisited. J Renal Inj Prev (2015) 0.80
Hypertensive renal injury is associated with gene variation affecting immune signaling. Circ Cardiovasc Genet (2014) 0.80
The Pivotal Role of a Novel Biomarker of Reactive Oxygen Species in Chronic Kidney Disease. Medicine (Baltimore) (2015) 0.79
P2 receptors in renal autoregulation. Curr Vasc Pharmacol (2014) 0.78
Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults. Neurology (2016) 0.78
Arterial Stiffness, Kidney Function, and Chronic Kidney Disease Progression. Pulse (Basel) (2013) 0.78
SPS3 Evidence Supports Intensive Blood Pressure Control. Circulation (2016) 0.78
Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD. J Am Soc Nephrol (2014) 0.77
Hemodynamic basis for the limited renal injury in rats with angiotensin II-induced hypertension. Am J Physiol Renal Physiol (2014) 0.77
Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis. Hypertension (2016) 0.76
Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy. Am J Physiol Renal Physiol (2015) 0.75
Hypercholesterolemia Impairs Nonstenotic Kidney Outcomes After Reversal of Experimental Renovascular Hypertension. Am J Hypertens (2016) 0.75
Increased Blood Pressure Variability Prior to Chronic Kidney Disease Exacerbates Renal Dysfunction in Rats. Front Physiol (2016) 0.75
Evaluation of Renal-Hepatic Functional Indices and Blood Pressure Based on the Progress of Time in a Rat Model of Chronic Kidney Disease. Nephrourol Mon (2016) 0.75
Pentosan polysulfate preserves renal microvascular P2X1 receptor reactivity and autoregulatory behavior in DOCA-salt hypertensive rats. Am J Physiol Renal Physiol (2015) 0.75
Renal perfusion index reflects cardiac systolic function in chronic cardio-renal syndrome. Med Sci Monit (2015) 0.75
High serum creatinine nonlinearity: a renal vital sign? Am J Physiol Renal Physiol (2016) 0.75
Relationship between diurnal blood pressure and renal histopathological changes in white coat hypertension. J Nephrol (2017) 0.75
Developmental Origins and Nephron Endowment in Hypertension. Front Pediatr (2017) 0.75
Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease. Hypertension (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (2010) 16.00
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Cell biology of the glomerular podocyte. Physiol Rev (2003) 6.85
K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis (2004) 6.66
Signaling mechanisms underlying the vascular myogenic response. Physiol Rev (1999) 4.89
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol (1981) 4.75
Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol (2010) 3.75
Mouse models of diabetic nephropathy. J Am Soc Nephrol (2009) 3.74
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int (1996) 2.97
Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol (2010) 2.55
Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int (2011) 2.28
Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension (2008) 2.24
Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension (2004) 1.83
Toward a unified theory of renal progression. Annu Rev Med (2006) 1.81
Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol (2006) 1.79
Blood pressure influences end-stage renal disease of Cd151 knockout mice. J Clin Invest (2011) 1.75
Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int (2002) 1.69
Protective importance of the myogenic response in the renal circulation. Hypertension (2009) 1.67
Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation. Kidney Int (2000) 1.66
Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol (1995) 1.65
Adverse renal consequences of obesity. Am J Physiol Renal Physiol (2008) 1.62
Assessment of renal autoregulation. Am J Physiol Renal Physiol (2007) 1.62
Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens (2008) 1.59
Elevated arterial pressure impairs autoregulation independently of AT(1) receptor activation. J Hypertens (2004) 1.58
Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation. Hypertension (2010) 1.54
The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol (2010) 1.46
Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. Lab Invest (2005) 1.38
Mechanisms of renal blood flow autoregulation: dynamics and contributions. Am J Physiol Regul Integr Comp Physiol (2006) 1.38
Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney. Nephrol Dial Transplant (2009) 1.37
Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade. Clin J Am Soc Nephrol (2006) 1.28
Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol (2011) 1.26
TRP channels and mechanosensory transduction: insights into the arterial myogenic response. Pflugers Arch (2008) 1.24
Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase. J Am Soc Nephrol (2003) 1.21
Asymmetric dimethylarginine in angiotensin II-induced hypertension. Am J Physiol Regul Integr Comp Physiol (2009) 1.20
Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol (2002) 1.19
Importance of nitric oxide in the control of renal hemodynamics. Kidney Int (1996) 1.17
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int (2010) 1.16
TGF-beta impairs renal autoregulation via generation of ROS. Am J Physiol Renal Physiol (2005) 1.13
Nitric oxide synthase derangements and hypertension in kidney disease. Curr Opin Nephrol Hypertens (2012) 1.11
Structure-stabilizing forces in the glomerular tuft. J Am Soc Nephrol (1995) 1.11
Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest (1995) 1.09
Glomerulotubular balance, tubuloglomerular feedback, and salt homeostasis. J Am Soc Nephrol (2008) 1.07
Renal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockade. Am J Physiol Renal Physiol (2010) 1.07
Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy. J Am Soc Nephrol (1995) 1.05
Effects of glomerular filtration dynamics on the glomerular permeability coefficient. Am J Physiol (1981) 1.03
p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice. Hypertension (2011) 1.02
Superoxide modulates myogenic contractions of mouse afferent arterioles. Hypertension (2011) 1.02
Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat. J Am Soc Nephrol (2000) 1.01
Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats. J Am Soc Nephrol (1999) 1.00
Altered whole kidney blood flow autoregulation in a mouse model of reduced beta-ENaC. Am J Physiol Renal Physiol (2009) 0.99
Interaction between nitric oxide and renal myogenic autoregulation in normotensive and hypertensive rats. Can J Physiol Pharmacol (2001) 0.96
The vascular pole of the renal glomerulus of rat. Adv Anat Embryol Cell Biol (1998) 0.95
Unexpected effect of angiotensin AT1 receptor blockade on tubuloglomerular feedback in early subtotal nephrectomy. Am J Physiol Renal Physiol (2009) 0.94
Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance. Am J Physiol Renal Physiol (2006) 0.94
Systolic and mean blood pressures and afferent arteriolar myogenic response dynamics: a modeling approach. Am J Physiol Regul Integr Comp Physiol (2008) 0.93
Alterations in basal protein kinase C activity modulate renal afferent arteriolar myogenic reactivity. Am J Physiol (1998) 0.92
High-NaCl intake impairs dynamic autoregulation of renal blood flow in ANG II-infused rats. Am J Physiol Regul Integr Comp Physiol (2010) 0.92
A mathematical model of the myogenic response to systolic pressure in the afferent arteriole. Am J Physiol Renal Physiol (2010) 0.92
Radiotelemetric BP monitoring, antihypertensives and glomeruloprotection in remnant kidney model. Kidney Int (1994) 0.92
Notch3 is essential for regulation of the renal vascular tone. Hypertension (2011) 0.91
Absence of glomerular injury or nephron loss in a normotensive rat remnant kidney model. Kidney Int (1990) 0.91
Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X1 receptor activation. Am J Physiol Renal Physiol (2010) 0.89
Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat. Kidney Int (2004) 0.89
Lewis K. Dahl Memorial Lecture. Mysteries of renal autoregulation. Hypertension (2008) 0.88
P2X1 receptor-mediated vasoconstriction of afferent arterioles in angiotensin II-infused hypertensive rats fed a high-salt diet. Hypertension (2011) 0.87
Large BP-dependent and -independent differences in susceptibility to nephropathy after nitric oxide inhibition in Sprague-Dawley rats from two major suppliers. Am J Physiol Renal Physiol (2011) 0.87
Role of angiotensin II in dynamic renal blood flow autoregulation of the conscious dog. J Physiol (2002) 0.86
Renal inflammation and elevated blood pressure in a mouse model of reduced {beta}-ENaC. Am J Physiol Renal Physiol (2011) 0.84
Hypertension and chronic kidney disease progression: why the suboptimal outcomes? Am J Med (2012) 0.83
Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury. Clin Exp Nephrol (2011) 0.83
Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS. J Physiol (2011) 0.82
Glomerular ultrafiltration dynamics: euvolemic and plasma volume-expanded rats. Am J Physiol (1980) 0.82
False claims of blood pressure-independent protection by blockade of the renin angiotensin aldosterone system? Hypertension (2003) 0.81
Losartan protects mesenteric arteries from ROS-associated decrease in myogenic constriction following 5/6 nephrectomy. J Renin Angiotensin Aldosterone Syst (2011) 0.81
Cellular and ionic signal transduction mechanisms for the mechanical activation of renal arterial vascular smooth muscle. J Am Soc Nephrol (1993) 0.81
The compensated and the decompensated form of benign nephrosclerosis. Pathol Res Pract (1982) 0.81
Role of connexin40 in the autoregulatory response of the afferent arteriole. Am J Physiol Renal Physiol (2012) 0.80
Angiotensin II type 2 receptor in chronic kidney disease: the good side of angiotensin II? Kidney Int (2009) 0.78
Facilitation of renal autoregulation by angiotensin II is mediated through modulation of nitric oxide. Acta Physiol Scand (2003) 0.78
Segment-specific differences in the inward rectifier K(+) current along the renal interlobular artery. Cardiovasc Res (2011) 0.77
The benefits of renin-angiotensin blockade in hypertension are dependent on blood-pressure lowering. Nat Clin Pract Nephrol (2006) 0.77
Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol (2010) 3.25
Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension (2004) 1.83
Recommendations for blood pressure measurement in humans and experimental animals: part 2: blood pressure measurement in experimental animals: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Arterioscler Thromb Vasc Biol (2005) 1.82
Protective importance of the myogenic response in the renal circulation. Hypertension (2009) 1.67
Role of epithelial sodium channels in the renal myogenic response? Hypertension (2009) 1.52
A highly sensitive technique to measure myosin regulatory light chain phosphorylation: the first quantification in renal arterioles. Am J Physiol Renal Physiol (2008) 1.20
Effects of amiloride, benzamil, and alterations in extracellular Na+ on the rat afferent arteriole and its myogenic response. Am J Physiol Renal Physiol (2008) 1.20
PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis. Am J Physiol Renal Physiol (2012) 1.07
Active hyperemia and vascular conductance differ between men and women for an isometric fatiguing contraction. J Appl Physiol (1985) (2006) 1.04
"Step" vs. "dynamic" autoregulation: implications for susceptibility to hypertensive injury. Am J Physiol Renal Physiol (2003) 0.99
Effects of calcium channel blockers on "dynamic" and "steady-state step" renal autoregulation. Am J Physiol Renal Physiol (2004) 0.97
Differential effects of salt on renal hemodynamics and potential pressure transmission in stroke-prone and stroke-resistant spontaneously hypertensive rats. Am J Physiol Renal Physiol (2005) 0.97
Systolic blood pressure as the trigger for the renal myogenic response: protective or autoregulatory? Curr Opin Nephrol Hypertens (2006) 0.96
Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance. Am J Physiol Renal Physiol (2006) 0.94
Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee. Arterioscler Thromb Vasc Biol (2005) 0.94
Long-term renal consequences of hypertension for normal and diseased kidneys. Curr Opin Nephrol Hypertens (2002) 0.93
Systolic and mean blood pressures and afferent arteriolar myogenic response dynamics: a modeling approach. Am J Physiol Regul Integr Comp Physiol (2008) 0.93
Genetic predictions of prion disease susceptibility in carnivore species based on variability of the prion gene coding region. PLoS One (2012) 0.90
Determinants of renal microvascular response to ACh: afferent and efferent arteriolar actions of EDHF. Am J Physiol Renal Physiol (2003) 0.86
Determinants of renal afferent arteriolar actions of bradykinin: evidence that multiple pathways mediate responses attributed to EDHF. Am J Physiol Renal Physiol (2003) 0.84
Inward rectifier K(+) currents and Kir2.1 expression in renal afferent and efferent arterioles. J Am Soc Nephrol (2008) 0.83
Hypertension and chronic kidney disease progression: why the suboptimal outcomes? Am J Med (2012) 0.83
Voltage-activated Ca(2+) channels in rat renal afferent and efferent myocytes: no evidence for the T-type Ca(2+) current. Cardiovasc Res (2012) 0.82
Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney. Am J Physiol Renal Physiol (2003) 0.82
Blood pressure-renal blood flow relationships in conscious angiotensin II- and phenylephrine-infused rats. Am J Physiol Renal Physiol (2013) 0.81
PAR-2 elicits afferent arteriolar vasodilation by NO-dependent and NO-independent actions. Am J Physiol Renal Physiol (2002) 0.81
Myosin heavy chain expression in renal afferent and efferent arterioles: relationship to contractile kinetics and function. FASEB J (2003) 0.81
Effects of inhibition of the Na+/K+/2Cl- cotransporter on myogenic and angiotensin II responses of the rat afferent arteriole. Am J Physiol Renal Physiol (2006) 0.80
The effect of high-load vs. high-repetition training on endurance performance. J Strength Cond Res (2004) 0.80
Redundant signaling mechanisms contribute to the vasodilatory response of the afferent arteriole to proteinase-activated receptor-2. Am J Physiol Renal Physiol (2004) 0.80
Chronic kidney disease: blood-pressure targets in chronic kidney disease. Nat Rev Nephrol (2010) 0.80
Glomerular endothelial PI3 kinase-α couples to VEGFR2, but is not required for eNOS activation. Am J Physiol Renal Physiol (2011) 0.79
Bighorn sheep (Ovis canadensis) sinus tumors are associated with coinfections by potentially pathogenic bacteria in the upper respiratory tract. J Wildl Dis (2015) 0.79
The benefits of renin-angiotensin blockade in hypertension are dependent on blood-pressure lowering. Nat Clin Pract Nephrol (2006) 0.77
Segment-specific differences in the inward rectifier K(+) current along the renal interlobular artery. Cardiovasc Res (2011) 0.77
Inward rectifier currents in pericytes. Am J Physiol Regul Integr Comp Physiol (2006) 0.76
Increased genetic susceptibility to renal damage in the stroke-prone spontaneously hypertensive rat. Kidney Int (2002) 0.76
Uncritical acceptance of combination treatment of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in nondiabetic renal disease trial results. Hypertension (2008) 0.75
Characterization of dynamics in renal autoregulation using volterra models. IEEE Trans Biomed Eng (2006) 0.75
Basic science: hypertensive target organ damage. J Am Soc Hypertens (2015) 0.75